Combined Therapy for Obese Type 2 Diabetes: Suppertime Mixed Insulin with Daytime Sulfonylurea
- 1 March 1992
- journal article
- clinical trial
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 303 (3) , 151-156
- https://doi.org/10.1097/00000441-199203000-00003
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Evening Insulin StrategyDiabetes Care, 1990
- Combination Therapy With Insulin and Sulfonylureas for Type II DiabetesDiabetes Care, 1990
- Combination Insulin-Sulfonylurea TherapyDiabetes Care, 1990
- Insulin as Risk Factor for Vascular DiseaseDiabetes Care, 1990
- Efficacy of Bedtime NPH Insulin With Daytime Sulfonylurea for Subpopulation of Type II Diabetic SubjectsDiabetes Care, 1989
- Low-Dose Bedtime NPH Insulin in Treatment of Secondary Failure to GlyburideDiabetes Care, 1989
- Hyperglycemia, recognized and unrecognized, as a risk factor for stroke and transient ischemic attacks.Stroke, 1982
- Determination of Free and Total Insulin and C-Peptide in Insulin-treated DiabeticsDiabetes, 1977
- A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated PatientsDiabetes, 1973
- Practical Methods for Plasma Lipoprotein Analysis1 1Work supported in part by the U.S. Atomic Energy Commission and by grants (HE06222 and FR00102) from the U.S. Public Health Service.Published by Elsevier ,1968